Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Martin Strüber, MD, Jochen T Cremer, MD, Bernhard Gohrbandt, MD, Christian Hagl, MD, Michaela Jankowski, MD, Birgit Völker, MD, Horst Rückoldt, MD, Michael Martin, PhD, Axel Haverich, MD The Annals of Thoracic Surgery Volume 68, Issue 4, Pages 1330-1335 (October 1999) DOI: 10.1016/S0003-4975(99)00729-8
Fig 1 Plasma concentration of complement factor C3a in patients before (prae) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 2 C1 esterase inhibitor (C1-INH) activity in patients before (prae) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 3 Plasma soluble tumor necrosis factor receptor 1 (TNF-R1) concentration in patients before (prae) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 4 Plasma soluble tumor necrosis factor receptor 2 (TNF-R2) concentration in patients before (prae) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 5 Plasma interleukin-8 (IL8) concentration in patients before (prae) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 6 Plasma interleukin-6 (IL6) concentration in patients before (pre) and 0, 2, 8, and 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The p value represents an intergroup comparison. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)
Fig 7 Maximum body temperature within 24 hours after minimally invasive direct coronary artery bypass (MIDCAB) (n = 12) and coronary artery bypass grafting (CABG) (n = 12). Data are expressed as the mean ± the standard deviation. The Annals of Thoracic Surgery 1999 68, 1330-1335DOI: (10.1016/S0003-4975(99)00729-8)